News Summary: Vaccine project aids poor countries

Published



TEAMWORK: Drugmakers Merck and GlaxoSmithKline are working with the Global Alliance for Vaccines and Immunization to provide hugely discounted cervical cancer vaccines to millions of girls in poor countries. That’s where the cancer kills most, because women rarely get Pap tests to detect it early.

THE PLAN: The project starts with pilot programs to vaccinate girls against the strains of human papilloma virus, or HPV, that usually cause cervical cancer. Eight Asian and African nations participating must show they can then set up national vaccination programs.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.